RUNX1 and acute myeloid leukemia: In the present report we describe an in vitro model that recapitulates the resistance of EVI1 overexpressing cells to drugs used in the chemotherapy of AML, and show that this effect may in part be mediated by upregulation of CDKN1A/p21/WAF.